<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32457286</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Fine tuning of the unfolded protein response by ISRIB improves neuronal survival in a model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>397</StartPage><MedlinePgn>397</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">397</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-020-2601-2</ELocationID><Abstract><AbstractText>Loss of protein folding homeostasis features many of the most prevalent neurodegenerative disorders. As coping mechanism to folding stress within the endoplasmic reticulum (ER), the unfolded protein response (UPR) comprises a set of signaling mechanisms that initiate a gene expression program to restore proteostasis, or when stress is chronic or overwhelming promote neuronal death. This fate-defining capacity of the UPR has been proposed to play a key role in amyotrophic lateral sclerosis (ALS). However, the several genetic or pharmacological attempts to explore the therapeutic potential of UPR modulation have produced conflicting observations. In order to establish the precise relationship between UPR signaling and neuronal death in ALS, we have developed a neuronal model where the toxicity of a familial ALS-causing allele (mutant G93A SOD1) and UPR activation can be longitudinally monitored in single neurons over the process of neurodegeneration by automated microscopy. Using fluorescent UPR reporters we established the temporal and causal relationship between UPR and neuronal death by Cox regression models. Pharmacological inhibition of discrete UPR processes allowed us to establish the contribution of PERK (PKR-like ER kinase) and IRE1 (inositol-requiring enzyme-1) mechanisms to neuronal fate. Importantly, inhibition of PERK signaling with its downstream inhibitor ISRIB, but not with the direct PERK kinase inhibitor GSK2606414, significantly enhanced the survival of G93A SOD1-expressing neurons. Characterization of the inhibitory properties of both drugs under ER stress revealed that in neurons (but not in glial cells) ISRIB overruled only part of the translational program imposed by PERK, relieving the general inhibition of translation, but maintaining the privileged translation of ATF4 (activating transcription factor 4) messenger RNA. Surprisingly, the fine-tuning of the PERK output in G93A SOD1-expressing neurons led to a reduction of IRE1-dependent signaling. Together, our findings identify ISRIB-mediated translational reprogramming as a new potential ALS therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bugallo</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Therapy and Regulation of Gene Expression Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDISNA, 31008, Pamplona, Navarra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marlin</LastName><ForeName>El&#xed;as</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gene Therapy and Regulation of Gene Expression Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDISNA, 31008, Pamplona, Navarra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baltan&#xe1;s</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDISNA, 31008, Pamplona, Navarra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toledo</LastName><ForeName>Estefan&#xed;a</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IDISNA, 31008, Pamplona, Navarra, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red &#xc1;rea de Fisiopatolog&#xed;a de la Obesidad y la Nutrici&#xf3;n (CIBEROBN), 28029, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrero</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gene Therapy and Regulation of Gene Expression Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDISNA, 31008, Pamplona, Navarra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinueza-Gavilanes</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDISNA, 31008, Pamplona, Navarra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larrea</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neuroscience Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDISNA, 31008, Pamplona, Navarra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Arrasate</LastName><ForeName>Montserrat</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8911-8990</Identifier><AffiliationInfo><Affiliation>Neuroscience Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain. marrasatei@unav.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDISNA, 31008, Pamplona, Navarra, Spain. marrasatei@unav.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Arag&#xf3;n</LastName><ForeName>Tom&#xe1;s</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1700-2729</Identifier><AffiliationInfo><Affiliation>Gene Therapy and Regulation of Gene Expression Program, Center for Applied Medical Research (CIMA), University of Navarra, 31008, Pamplona, Spain. taragon@unav.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IDISNA, 31008, Pamplona, Navarra, Spain. taragon@unav.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599093">2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C576403">7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000081">Acetamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003514">Cyclohexylamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007211">Indoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C117035">PERK kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D019892">eIF-2 Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>JAC85A2161</RegistryNumber><NameOfSubstance UI="D000225">Adenine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000081" MajorTopicYN="N">Acetamides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000225" MajorTopicYN="N">Adenine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003514" MajorTopicYN="N">Cyclohexylamines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059865" MajorTopicYN="N">Endoplasmic Reticulum Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="Y">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056811" MajorTopicYN="Y">Unfolded Protein Response</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019892" MajorTopicYN="N">eIF-2 Kinase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32457286</ArticleId><ArticleId IdType="pmc">PMC7250913</ArticleId><ArticleId IdType="doi">10.1038/s41419-020-2601-2</ArticleId><ArticleId IdType="pii">10.1038/s41419-020-2601-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maurel M, Chevet E, Tavernier J, Gerlo S. Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem. Sci. 2014;39:245&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">24657016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Saxena S. ER stress and the unfolded protein response in neurodegeneration. Nat. Rev. Neurol. 2017;13:477&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">28731040</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol. Cell. 2018;69:169&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">29107536</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334:1081&#x2013;1086.</Citation><ArticleIdList><ArticleId IdType="pubmed">22116877</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding HP, et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell. 2000;6:1099&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pubmed">11106749</ArticleId></ArticleIdList></Reference><Reference><Citation>Marciniak SJ, et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004;18:3066&#x2013;3077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC535917</ArticleId><ArticleId IdType="pubmed">15601821</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol. 2013;15:481&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3692270</ArticleId><ArticleId IdType="pubmed">23624402</ArticleId></ArticleIdList></Reference><Reference><Citation>Novoa I, Zeng H, Harding HP, Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J. Cell Biol. 2001;153:1011&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2174339</ArticleId><ArticleId IdType="pubmed">11381086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ron D. Translational control in the endoplasmic reticulum stress response. J. Clin. Invest. 2002;110:1383&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151821</ArticleId><ArticleId IdType="pubmed">12438433</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding HP, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell. 2003;11:619&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">12667446</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakos-Zebrucka K, et al. The integrated stress response. EMBO Rep. 2016;17:1374&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5048378</ArticleId><ArticleId IdType="pubmed">27629041</ArticleId></ArticleIdList></Reference><Reference><Citation>Calfon M, et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature. 2002;415:92&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">11780124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Liang FX, Wang X. A synthetic biology approach identifies the mammalian UPR RNA ligase RtcB. Mol. Cell. 2014;55:758&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4156904</ArticleId><ArticleId IdType="pubmed">25087875</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurkin J, et al. The mammalian tRNA ligase complex mediates splicing of XBP1 mRNA and controlsantibody secretion in plasma cells. EMBO J. 2014;33:2922&#x2013;2936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4282640</ArticleId><ArticleId IdType="pubmed">25378478</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 2001;107:881&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pubmed">11779464</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman, O. et al. Amyotrophiclateral sclerosis. NatRev Dis Primers 3, 10.1038/nrdp.2017.71 (2017).</Citation></Reference><Reference><Citation>Taylor JP, Brown RH, Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362.</Citation><ArticleIdList><ArticleId IdType="pubmed">8332197</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008;4:e1000193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva EV, et al. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain. 2007;130:3111&#x2013;3123.</Citation><ArticleIdList><ArticleId IdType="pubmed">17716997</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkin JD, et al. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol. Dis. 2008;30:400&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pubmed">18440237</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, et al. Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice. Neurobiol. Dis. 2009;36:470&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">19733664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, et al. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009;23:2294&#x2013;2306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758741</ArticleId><ArticleId IdType="pubmed">19762508</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015;18:1175&#x2013;1182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14:781&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, et al. CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat. Genet. 2018;50:603&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5893388</ArticleId><ArticleId IdType="pubmed">29507424</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Cabuy E, Caroni P. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 2009;12:627&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A, et al. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron. 2014;81:333&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, et al. Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc. Natl Acad. Sci. USA. 2015;112:E6993&#x2013;E7002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang HQ, et al. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neuroscience. 2014;277:132&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">24699224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Popko B, Tixier E, Roos RP. Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis. Neurobiol. Dis. 2014;71:317&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4179984</ArticleId><ArticleId IdType="pubmed">25134731</ArticleId></ArticleIdList></Reference><Reference><Citation>Das I, et al. Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science. 2015;348:239&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4490275</ArticleId><ArticleId IdType="pubmed">25859045</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Popko B, Roos RP. An enhanced integrated stress response ameliorates mutant SOD1-induced ALS. Hum. Mol. Genet. 2014;23:2629&#x2013;2638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3990163</ArticleId><ArticleId IdType="pubmed">24368417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Popko B, Roos RP. The unfolded protein response in familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 2011;20:1008&#x2013;1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3033190</ArticleId><ArticleId IdType="pubmed">21159797</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzhashiashvili Y, Monckton CP, Shah HS, Kunjamma RB, Popko B. The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS. Neurobiol. Dis. 2019;127:527&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6588429</ArticleId><ArticleId IdType="pubmed">30923003</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira FG, et al. Guanabenz treatment accelerates disease in a mutant SOD1 mouse model of ALS. PLoS ONE. 2015;10:e0135570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4545826</ArticleId><ArticleId IdType="pubmed">26288094</ArticleId></ArticleIdList></Reference><Reference><Citation>Matus S, Lopez E, Valenzuela V, Nassif M, Hetz C. Functional contribution of the transcription factor ATF4 to the pathogenesis of amyotrophic lateral sclerosis. PLoS ONE. 2013;8:e66672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715499</ArticleId><ArticleId IdType="pubmed">23874395</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro A, et al. Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo. Neurobiol. Dis. 2013;55:64&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">23567652</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, et al. Therapeutic modulation of eIF2alpha phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 2014;46:152&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J, et al. Quantitative relationships between Huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into Huntington's disease molecular pathogenesis. J. Neurosci. 2010;30:10541&#x2013;10550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3078518</ArticleId><ArticleId IdType="pubmed">20685997</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G, et al. Nrf2 mitigates LRRK2- and alpha-synuclein-induced neurodegeneration by modulating proteostasis. Proc. Natl Acad. Sci. USA. 2017;114:1165&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5293055</ArticleId><ArticleId IdType="pubmed">28028237</ArticleId></ArticleIdList></Reference><Reference><Citation>Inigo-Marco I, et al. E46K alpha-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation. Proc. Natl Acad. Sci. USA. 2017;114:E8274&#x2013;E8283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5625897</ArticleId><ArticleId IdType="pubmed">28900007</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores BN, et al. An intramolecular salt bridge linking TDP43 RNA binding, protein stability, and TDP43-dependent neurodegeneration. Cell Rep. 2019;27:1133&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431:805&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">15483602</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrasate M, Finkbeiner S. Automated microscope system for determining factors that predict neuronal fate. Proc. Natl Acad. Sci. USA. 2005;102:3840&#x2013;3845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC553329</ArticleId><ArticleId IdType="pubmed">15738408</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J, et al. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat. Chem. Biol. 2011;7:925&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3271120</ArticleId><ArticleId IdType="pubmed">22037470</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 2014;10:677&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto K, Yoshida H, Kokame K, Kaufman RJ, Mori K. Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. J. Biochem. 2004;136:343&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">15598891</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J. Biol. Chem. 2000;275:27013&#x2013;27020.</Citation><ArticleIdList><ArticleId IdType="pubmed">10856300</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwawaki T, Akai R, Kohno K, Miura M. A transgenic mouse model for monitoring endoplasmic reticulum stress. Nat. Med. 2004;10:98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">14702639</ArticleId></ArticleIdList></Reference><Reference><Citation>Axten, J. M. et al. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-p yrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J. Med. Chem. 55, 7193&#x2013;7207 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22827572</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidrauski C, et al. Pharmacological brake-release of mRNA translation enhances cognitive memory. Elife. 2013;2:e00498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3667625</ArticleId><ArticleId IdType="pubmed">23741617</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross BC, et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc. Natl Acad. Sci. USA. 2012;109:E869&#x2013;E878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3326519</ArticleId><ArticleId IdType="pubmed">22315414</ArticleId></ArticleIdList></Reference><Reference><Citation>Crespillo-Casado, A., Chambers, J. E., Fischer, P. M., Marciniak, S. J. &amp; Ron, D. PPP1R15A-mediated dephosphorylation of eIF2alpha is unaffected by Sephin1 or Guanabenz. Elife6, 10.7554/eLife.26109 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5429092</ArticleId><ArticleId IdType="pubmed">28447936</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey S, et al. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. J. Clin. Invest. 2015;125:2592&#x2013;2608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4563676</ArticleId><ArticleId IdType="pubmed">26011642</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieterich DC, et al. In situ visualization and dynamics of newly synthesized proteins in rat hippocampal neurons. Nat. Neurosci. 2010;13:897&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2920597</ArticleId><ArticleId IdType="pubmed">20543841</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday, M.et al. Partialrestoration of protein synthesis rates by the small molecule ISRIB preventsneurodegeneration without pancreatic toxicity. Cell Death Dis.6, 10.1038/cddis.2015.49 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4385927</ArticleId><ArticleId IdType="pubmed">25741597</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, Y. L. et al. eIF2B activator prevents neurological defects caused by a chronic integrated stress response. Elife8, 10.7554/eLife.42940 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6326728</ArticleId><ArticleId IdType="pubmed">30624206</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai, J. C. et al. Structure of the nucleotide exchange factor eIF2B reveals mechanism of memory-enhancing molecule. Science359, 10.1126/science.aaq0939 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120582</ArticleId><ArticleId IdType="pubmed">29599213</ArticleId></ArticleIdList></Reference><Reference><Citation>Zyryanova AF, et al. Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B. Science. 2018;359:1533&#x2013;1536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5889100</ArticleId><ArticleId IdType="pubmed">29599245</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabouw HH, et al. Small molecule ISRIB suppresses the integrated stress response within a defined window of activation. Proc. Natl Acad. Sci. USA. 2019;116:2097&#x2013;2102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6369741</ArticleId><ArticleId IdType="pubmed">30674674</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagnetta R, et al. Noncanonical modulation of the eIF2 pathway controls an increase in local translation during neural wiring. Mol. Cell. 2019;73:474&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6375727</ArticleId><ArticleId IdType="pubmed">30595434</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H, et al. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 2008;22:1451&#x2013;1464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2418582</ArticleId><ArticleId IdType="pubmed">18519638</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, et al. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J. Neurochem. 2004;90:231&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">15198682</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson TL, Cleveland DW. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 1999;2:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>